Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 13
Treatment-assignment count: 0
Stratification count: 0
Cdx Established Context
HER2 / ERBB2 expression
gastric cancer · Immune Checkpoint Inhibitor
HER2 / ERBB2 expression is flagged as cdx established context because public trials show inclusion required evidence in 14 contexts. FDA CDx context exists. Threshold text varies across public records.
Threshold snippets
Fragmentation view
Threshold count: 10
Common snippets: PD-L1 CPS ≥10 | PD-L1 CPS ≥1 | PD-L1 CPS ≥1
Threshold label: Fragmented
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: Medium
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT03505320 | https://clinicaltrials.gov/study/NCT03342937 | https://clinicaltrials.gov/study/NCT02494583 | https://clinicaltrials.gov/study/NCT02689284 | https://clinicaltrials.gov/study/NCT03647969 | https://clinicaltrials.gov/study/NCT07432295 | https://clinicaltrials.gov/study/NCT03959293 | https://clinicaltrials.gov/study/NCT05535569 | https://clinicaltrials.gov/study/NCT03407976 | https://clinicaltrials.gov/study/NCT07673887 | https://clinicaltrials.gov/study/NCT07431281 | https://clinicaltrials.gov/study/NCT06901531 | https://clinicaltrials.gov/study/NCT07270991 | https://clinicaltrials.gov/study/NCT05365581